- Home
- CLLS vs SLND Comparison
CLLS vs SLND Comparison
Compare CLLS & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- SLND
- Stock Information
- Founded
- CLLS 1999
- SLND 1900
- Country
- CLLS France
- SLND United States
- Employees
- CLLS 216
- SLND 2500
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- CLLS Health Care
- SLND Industrials
- Exchange
- CLLS Nasdaq
- SLND Nasdaq
- Market Cap
- CLLS 148.1M
- SLND 188.8M
- IPO Year
- CLLS 2007
- SLND N/A
- Fundamental
- Price
- CLLS $1.48
- SLND $3.50
- Analyst Decision
- CLLS Buy
- SLND Buy
- Analyst Count
- CLLS 3
- SLND 2
- Target Price
- CLLS $7.00
- SLND $5.50
- AVG Volume (30 Days)
- CLLS 235.1K
- SLND 45.7K
- Earning Date
- CLLS 11-04-2024
- SLND 03-03-2025
- Dividend Yield
- CLLS N/A
- SLND N/A
- EPS Growth
- CLLS N/A
- SLND N/A
- EPS
- CLLS N/A
- SLND N/A
- Revenue
- CLLS $36,042,000.00
- SLND $1,029,117,999.00
- Revenue This Year
- CLLS $387.77
- SLND N/A
- Revenue Next Year
- CLLS $11.14
- SLND $6.18
- P/E Ratio
- CLLS N/A
- SLND N/A
- Revenue Growth
- CLLS 46.96
- SLND N/A
- 52 Week Low
- CLLS $1.41
- SLND $1.85
- 52 Week High
- CLLS $3.38
- SLND $6.16
- Technical
- Relative Strength Index (RSI)
- CLLS 38.66
- SLND 54.30
- Support Level
- CLLS $1.65
- SLND $3.15
- Resistance Level
- CLLS $2.23
- SLND $3.86
- Average True Range (ATR)
- CLLS 0.18
- SLND 0.26
- MACD
- CLLS -0.03
- SLND -0.00
- Stochastic Oscillator
- CLLS 8.54
- SLND 49.30
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.